Minocycline HCl

Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis. Moxifloxacin can be synthesized through a 12 step sequence from the classical 4-quinolone-3-carboxylic acid template. Some advantages of Moxifloxacin over Ciprofloxacin, another of Bayer's launched quinolones, have been shown, i.e. an enhanced activity against Gram-positive bacteria (Streptococcus pneumoniae, Clostndium pneumoniae), a favorable pharmacokinetic profile (good tissue penetration and plasma concentrations above MICs) and a lack of phototoxicity (UVA irradiation). 

Moxifloxacin can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli, pneumococcus, acute attack of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad spectrum antibiotics. It has strong antimicrobial activity against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae. It is clinically used to treat acute sinus adenitis, acute exacerbation of chronic bronchitis) community acquired pneumonia, as well as non-complications of skin and soft tissue 

Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.

Me gelek kargehên kalîteya bilind bi hevkariyek kûr heye, ku dikarin ji we re hilberên kalîteya bilind û bihayên reqabetê peyda bikin. Û em dikarin ji bo kirînên mezin erzanan jî bidin. Û em bi gelek pargîdaniyên barkêş ên profesyonel re hevkariyê dikin, dikarin hilberan bi ewlehî û bi aramî radestî destên we bikin. Dema radestkirinê piştî pejirandina dravdanê 3-20 rojan e.

Minocycline Hydrochloride is a semisynthetic tetracycline class,broad-spectrum antibiotics in the tetracycline class of antibiotics,the product of the strongest activity.To gram-positive bacteria including tetracycline resistance of staphylococcus aureus,streptococcus and gram-negative bacteria such as gonorrhea netheril bacteria have a strong role; For chlamydia trachomatis and dissolving urea mycoplasma also has better inhibition.

1. Ma hûn kargehek an pargîdaniyek bazirganî ne?
Em pargîdaniyek in ku pîşesazî û bazirganiyê entegre dike, karûbarê yek-stop peyda dike. OEM dikare were pejirandin.

2. Ma hûn nimûne pêşkêş dikin? Ew belaş an zêde ye?
Nimûneyên belaş. Pêdivî ye ku heqê barkirina nimûneyê ji hêla we ve were dayîn.

3. Hûn belgeyên ku bi kontrola kalîteyê ve girêdayî ne?
Sertîfîkaya ISO 9001: 2008 ji bo misogerkirina kalîteyê.

4. Divê ez çi peyda bikim da ku jêderkek bistînim?
Ji kerema xwe celebê hilberê ku hûn hewce ne, hêjmara fermanê, navnîşan û hewcedariyên taybetî me agahdar bikin. Dê di wextê de ji bo referansa we veqetandin were çêkirin.

5. Hûn rêbazek dravdanê çawa tercîh dikin? Mercên çawa têne qebûl kirin?
Mercên Radestkirina Pejirandî: FOB, CFR, CIF, EXW;
Pereyê Tezmînata Qebûlkirî:USD;
Tîpa dravdana pejirandî: T/T, Yekîtiya Rojavayî; Paypal, Ewlekariya Bazirganî.
Zimanê axaftinê: Îngilîzî.